Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Cheng Hsu Wang"'
Autor:
Yen Min Huang, Cheng Hsu Wang, Jen Seng Huang, Kun Yun Yeh, Chien Hong Lai, Tsung Han Wu, Pei Hung Chang, Yueh Shih Chang, Yii Jenq Lan
Publikováno v:
Turkish Journal of Hematology, Vol 32, Iss 1, Pp 68-72 (2015)
Dasatinib is a potent second-generation tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The most common adverse event associated with dasatinib therapy is fluid retention, including pleural effusion. Dasatinib-related chyloth
Externí odkaz:
https://doaj.org/article/4b35945a42354dd789e7ecf9338c28f5
Autor:
Hong Li, Chi‐Ling Chiang, Kwang Joo Kwak, Xinyu Wang, Sital Doddi, Lakshmi V. Ramanathan, Sun M. Cho, Ya‐Chin Hou, Tai‐Shan Cheng, Xiaokui Mo, Yueh‐Shih Chang, Hui‐Lan Chang, Weiming Cheng, Wei‐Ni Tsai, Luong T. H. Nguyen, Junjie Pan, Yifan Ma, Xilal Y. Rima, Jingjing Zhang, Eduardo Reategui, Yeh‐Shiu Chu, Peter Mu‐Hsin Chang, Pei‐Hung Chang, Chi‐Ying F. Huang, Cheng‐Hsu Wang, Yan‐Shen Shan, Chung‐Pin Li, Martin Fleisher, L. James Lee
Publikováno v:
Advanced Science, Vol 11, Iss 11, Pp n/a-n/a (2024)
Abstract Detecting pancreatic duct adenocarcinoma (PDAC) in its early stages and predicting late‐stage patient prognosis undergoing chemotherapy is challenging. This work shows that the activation of specific oncogenes leads to elevated expression
Externí odkaz:
https://doaj.org/article/a765cae34104438aa7abecd26a692173
Autor:
Yu-Ching Lin, Cheng-Hsu Wang, Hang Huong Ling, Yi-Ping Pan, Pei-Hung Chang, Wen-Chi Chou, Fang-Ping Chen, Kun-Yun Yeh
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 388 (2022)
Only few prospective cohort trials have evaluated the risk factors for the 2-year mortality rate between two patient subgroups with locally advanced head and neck squamous cell carcinoma (LAHNSCC): oral cavity cancer with adjuvant concurrent chemorad
Externí odkaz:
https://doaj.org/article/18f3c5c3fc814083a23aecd5c44ce34c
Autor:
Yu-Ching Lin, Hang Huong Ling, Pei-Hung Chang, Yi-Ping Pan, Cheng-Hsu Wang, Wen-Chi Chou, Fang-Ping Chen, Kun-Yun Yeh
Publikováno v:
Diagnostics, Vol 11, Iss 7, p 1203 (2021)
Few prospective cohort trials have evaluated the potential risk factors of early treatment failure of locally advanced oral cavity squamous cell carcinoma (LAOCSCC) patients following the completion of postoperative adjuvant concurrent chemoradiother
Externí odkaz:
https://doaj.org/article/42db809972e1476cb08413ce64989dcc
Autor:
Kun-Yun Yeh, Hang Huong Ling, Shu-Hang Ng, Cheng-Hsu Wang, Pei-Hung Chang, Wen-Chi Chou, Fang-Ping Chen, Yu-Ching Lin
Publikováno v:
Diagnostics, Vol 11, Iss 2, p 309 (2021)
Background: This study investigates whether the appendicular skeletal muscle index (ASMI) was an independent prognostic predictor for patients with locally advanced head and neck cancer (LAHNC) receiving concurrent chemoradiotherapy (CCRT) and whethe
Externí odkaz:
https://doaj.org/article/fef44988b535436488eed5afaf4b5f4d
Autor:
Wen‐Chi Shen, Ming‐Mo Hou, Tai‐Lin Huang, Cheng‐Hsu Wang, Yen‐Min Huang, Jen‐Shi Chen, Mei‐Ling Chen
Publikováno v:
Journal of Clinical Nursing. 32:539-547
This study explored the effect of transdermal buprenorphine on quality of life and six symptoms in cancer patients with pain.Transdermal opioids offer advantages over traditional routes of administration. The impact of transdermal buprenorphine on qu
Autor:
Hang Huong Ling, Kun-Yun Yeh, Shu-Hang Ng, Cheng-Hsu Wang, Chien-Hong Lai, Tsung-Han Wu, Pei-Hung Chang, Wen-Chi Chou, Fang-Ping Chen, Yu-Ching Lin
Publikováno v:
Nutrients, Vol 12, Iss 3, p 836 (2020)
Study on the impact of pretreatment malnutrition on treatment outcomes in locally advanced head and neck cancer (LAHNC) patients is still lacking. We prospectively collected various malnutrition assessment methods including nutrition indexes, inflamm
Externí odkaz:
https://doaj.org/article/7a0d1854eaff4e489344776754d35808
Autor:
John WC Chang, Ming-Mo Hou, Jia-Juan Hsieh, Yun-Chung Cheung, Hung-Ming Wang, Jen-Shi Chen, Cheng-Hsu Wang, Chih-Hung Chen, Kun-Yun Yeh, Li-Ying Ou, Chia-Hsun Hsieh, Hong-Dar Isaac Wu, Ying-Tsong Chen, Il-Chi Chang, Shiu-Feng Huang
Publikováno v:
Biomedical Journal, Vol 38, Iss 3, Pp 221-228 (2015)
Background: The time schedules for response evaluation of epidermal growth factor receptor-tyrosine kinase Inhibitor (EGFR-TKI) in non-small cell lung cancer (NSCLC) patients are still ill-defined. Methods: Stage IIIB/IV patients with histologically
Externí odkaz:
https://doaj.org/article/173c658af2ba477082f7a463f7862dea
Autor:
Tai‐Lin Huang, Yen‐Min Huang, Min‐Mo Hou, Chang‐Hsien Lu, Tsu‐Yi Chao, Tai‐Jan Chiu, Yueh‐Shih Chang, Sheng‐Hao Lin, Ching‐Hsiung Lin, Yen‐Hao Chen, Cheng‐Hsu Wang, Jen‐Shi Chen, Wen‐Chi Shen
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 19
Buprenorphine is one of the strongest opioids used for the relief of cancer pain. This study aims to evaluate the real-world clinical experiences of transdermal buprenorphine used in moderate to severe cancer pain in the Asian population.This is an o
Autor:
Hang Huong Ling, Yi-Ping Pan, Chung-Wei Fan, Wen-Ko Tseng, Jen-Seng Huang, Tsung-Han Wu, Wen-Chi Chou, Cheng-Hsu Wang, Kun-Yun Yeh, Pei-Hung Chang
Publikováno v:
Nutrients, Vol 11, Iss 4, p 898 (2019)
Limited studies have assessed the associations of pretreatment serum glutamine level with clinicopathological characteristics and prognosis of colorectal cancer (CRC) patients. This study focuses on clarifying the clinical significance of baseline se
Externí odkaz:
https://doaj.org/article/171f1e4d37c14b3caf1536947701d72e